Evidence map›Paper›PMID 37064702›Full record

ArticleFrontiers in public health2023

Are the epidemic prevention facilities effective? How cities should choose epidemic prevention facilities: Taking Wuhan as an example.

Lei Hua, Rong Ran, Zhengxing Ni

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lei HuaSchool of Public Policy and Administration, Chongqing University, Chongqing, China.
Rong RanSchool of Public Policy and Administration, Chongqing University, Chongqing, China.
Zhengxing NiSchool of Public Policy and Administration, Chongqing University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic highlighted the limitations of urban public health emergency response capabilities. Taking Wuhan as an example, this study used breakpoint regression, kernel density analysis, overlay analysis, and accessibility analysis from Stata and ArcGIS, and divided epidemic prevention facilities into the basic epidemic prevention facilities (hospitals), and the emergency epidemic prevention facilities (mobile cabin hospitals) for further analysis. The results showed that over 70% of the basic epidemic prevention facilities in Wuhan were located in high density population areas. On the contrary, most of the emergency epidemic prevention facilities were located in low density population areas. The local treatment effect of the implementation of the emergency epidemic prevention facility policy is about 1, indicating that there was a significant impact of emergency epidemic prevention facilities on outbreak control, which passed the bandwidth test. What's more, the analysis of the accessibility of residential points revealed that more than 67.3% of people from the residential points could arrive at the epidemic prevention facilities within 15 min, and only 0.1% of them took more than 20 min to arrive. Therefore, the epidemic prevention facilities can effectively curb the spread of the epidemic, and people from residential areas can quickly get there. This study summarized the spatial characteristics of epidemic prevention facilities in Wuhan and analyzed the importance of them, thus providing a new perspective for future research on upgrading the city's comprehensive disaster prevention system.

Indexed as

COVID-19CitiesDisease OutbreaksHospitalsHumansPandemicsaccessibility analyticitybreakpoint regressionCOVID-19epidemic prevention facilitiesurban safety

Identifiers

PMID37064702
PMCPMC10097902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.